Eli Lilly is a top pharmaceutical company based in Indianapolis, Indiana, USA
Eli Lilly is engaged in the discovery, development, manufacture and sale of pharmaceutical and animal health products worldwide.
Our report provides more detailed insight into the details of each deal. See: Partnering Deals and Alliances with Eli Lilly
Eli Lilly is a top pharmaceutical company based in Indianapolis, Indiana, USA.
The company was founded in 1876.
Eli Lilly is engaged in the discovery, development, manufacture and sale of pharmaceutical and animal health products worldwide.
The company has two core businesses; all focused on advancing innovations that provide better options and outcomes, enabling healthier lives.
- Pharmaceuticals – the company offers branded medicines, with a focus on cardiovascular, diabetes, critical care, oncology, neuroscience, men’s health and musculoskeletal.
- Animal health – the company complements its pharma business through its animal health subsidiary, Elanco, with a focus on animal protein production, companion animal health and food safety.
Eli Lilly has an active licensing partnering group that recognizes the significant role played by 3rd party collaborations in delivering great opportunities. Eli Lilly has a long history of partnering, building numerous collaborative partnerships more
Eli Lilly announced over 150 partnering / licensing deals since 2005, with over 14 deals in 2012 alone. Analysis of the partnering deals shows a strong emphasis on partnerships in metabolic, oncology, psychiatry, central nervous system and cardiovascular diseases more
Eli Lilly has also announced over 9 M&A deals since 2005, with the lead deals being the acquisition of Imclone Systems and Icos more
Our report provides more detailed insight into the details of each deal. See: Partnering Deals and Alliances with Eli Lilly
Examples of recent partnering and licensing deals announced by Eli Lilly can be viewed in Current Partnering's Eli Lilly partnering activity review article.
Examples of recent M&A deals announced by Eli Lilly can be viewed in Current Partnering's Eli Lilly M&A activity review article.
Our report provides more detailed insight into the details of each deal. See: Partnering Deals and Alliances with Eli Lilly
Available reports from Current Partnering
Report: Partnering Deals and Alliances with Eli Lilly
Report: Partnering Deals and Alliances with Big Pharma
Available resources for deal coverage for Eli Lilly
Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more
Read: more on Eli Lilly company profile, recent partnering, M&A and financing news and articles
Related
Report: Practical Guide to Finding Partners
View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value
View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value
View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making
View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity
Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now
Signup: Current Agreements Deals
Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now
View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk
View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk
